ID

13128

Descripción

Comparison of Intra-operative Radiotherapy With Post-operative Radiotherapy for Women With Early Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00983684

Link

https://clinicaltrials.gov/show/NCT00983684

Palabras clave

Versiones (1)
  1. 18/1/16 18/1/16 -
Subido en

18 de enero de 2016

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Invasive Breast Cancer NCT00983684

Inglés

Eligibility Invasive Breast Cancer NCT00983684

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
age 45 years or older
Descripción

age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
operable invasive breast cancer (t1 and small t2, n0-1, m0) confirmed by cytological or histological examination
Descripción

breast cancer

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0010819
UMLS CUI [1,2]
C0678222
UMLS CUI [2,1]
C0019638
UMLS CUI [2,2]
C0678222
suitable for breast conserving surgery
Descripción

surgery

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0038894
previously diagnosed and treated contralateral breast cancer may be entered but will be randomised to a separate stratum.
Descripción

contralateral breast cancer

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0678222
UMLS CUI [1,2]
C0441988
available for regular follow-up for at least ten years.
Descripción

compliance

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1321605
note: individual centres may wish to restrict entry to a more exactly defined subset of patients, in which case, only patients with these characteristics may be entered by that particular centre. for example, centres may decide at outset to recruit only women over 50 or even over 65 years of age. such policies must be pre-defined in writing and approved by the international steering committee.
Descripción

ID.6

Tipo de datos

text

Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
more than one obvious cancer in the same breast as diagnosed by clinical examination, mammography or ultrasonography.
Descripción

multifocal carcinoma

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0678222
UMLS CUI [1,2]
C0205292
bilateral breast cancer at the time of diagnosis.
Descripción

bilateral breast cancer

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0678222
UMLS CUI [1,2]
C0238767
ipsilateral breast had a previous cancer and/or irradiation.
Descripción

irradiation previous cancer

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1522449
UMLS CUI [2]
C0678222
patients known to have brca2 gene mutations, but testing for gene mutations is not required
Descripción

brca2

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0598034
lobular cancer or extensive intraductal component (eic =>25% of the tumour is intraductal) on core biopsy or initial pathology (if performed)
Descripción

biopsy, pathology

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0005558
UMLS CUI [2]
C0030664
patients undergoing primary medical treatment (hormones or chemotherapy) as initial treatment with neoadjuvant intent of reducing tumour size should be excluded; those given short duration (up to 4 weeks) systemic therapy can be included.
Descripción

neoadjuvant therapy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0600558
patients presenting with gross nodal disease, considered to be clinically malignant or proven cytologically or by scanning. in general, 4 or more positive nodes or extranodal spread are not suitable for targit alone and should receive ebrt as well. however, individual centres may decide that anything more than micrometastasis should receive ebrt.
Descripción

lymph nodes

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0024204
patients with any severe concomitant disease that may limit their life expectancy.
Descripción

comorbidity

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0009488
UMLS CUI [1,2]
C0392760
UMLS CUI [1,3]
C0023671
previous history of malignant disease does not preclude entry if the expectation of relapse-free survival at 10 years is 90% or greater.
Descripción

cancer

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0006826
any factor included as exclusion criterion in the local centre's treatment policy. this is particularly relevant to patients entered into the post pathology stratum.
Descripción

additional criteria

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0680251
no more than 30 days can have elapsed between last breast cancer surgery (not axillary) and entry into the trial for patients in the post-pathology stratification.
Descripción

time

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0040223
Volver a la parte superior de la página

Similar models

Eligibility Invasive Breast Cancer NCT00983684

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
age
Item
age 45 years or older
boolean
C0001779 (UMLS CUI [1])
breast cancer
Item
operable invasive breast cancer (t1 and small t2, n0-1, m0) confirmed by cytological or histological examination
boolean
C0010819 (UMLS CUI [1,1])
C0678222 (UMLS CUI [1,2])
C0019638 (UMLS CUI [2,1])
C0678222 (UMLS CUI [2,2])
surgery
Item
suitable for breast conserving surgery
boolean
C0038894 (UMLS CUI [1])
contralateral breast cancer
Item
previously diagnosed and treated contralateral breast cancer may be entered but will be randomised to a separate stratum.
boolean
C0678222 (UMLS CUI [1,1])
C0441988 (UMLS CUI [1,2])
compliance
Item
available for regular follow-up for at least ten years.
boolean
C1321605 (UMLS CUI [1])
ID.6
Item
note: individual centres may wish to restrict entry to a more exactly defined subset of patients, in which case, only patients with these characteristics may be entered by that particular centre. for example, centres may decide at outset to recruit only women over 50 or even over 65 years of age. such policies must be pre-defined in writing and approved by the international steering committee.
text
Item Group
C0680251 (UMLS CUI)
multifocal carcinoma
Item
more than one obvious cancer in the same breast as diagnosed by clinical examination, mammography or ultrasonography.
boolean
C0678222 (UMLS CUI [1,1])
C0205292 (UMLS CUI [1,2])
bilateral breast cancer
Item
bilateral breast cancer at the time of diagnosis.
boolean
C0678222 (UMLS CUI [1,1])
C0238767 (UMLS CUI [1,2])
irradiation previous cancer
Item
ipsilateral breast had a previous cancer and/or irradiation.
boolean
C1522449 (UMLS CUI [1])
C0678222 (UMLS CUI [2])
brca2
Item
patients known to have brca2 gene mutations, but testing for gene mutations is not required
boolean
C0598034 (UMLS CUI [1])
biopsy, pathology
Item
lobular cancer or extensive intraductal component (eic =>25% of the tumour is intraductal) on core biopsy or initial pathology (if performed)
boolean
C0005558 (UMLS CUI [1])
C0030664 (UMLS CUI [2])
neoadjuvant therapy
Item
patients undergoing primary medical treatment (hormones or chemotherapy) as initial treatment with neoadjuvant intent of reducing tumour size should be excluded; those given short duration (up to 4 weeks) systemic therapy can be included.
boolean
C0600558 (UMLS CUI [1])
lymph nodes
Item
patients presenting with gross nodal disease, considered to be clinically malignant or proven cytologically or by scanning. in general, 4 or more positive nodes or extranodal spread are not suitable for targit alone and should receive ebrt as well. however, individual centres may decide that anything more than micrometastasis should receive ebrt.
boolean
C0024204 (UMLS CUI [1])
comorbidity
Item
patients with any severe concomitant disease that may limit their life expectancy.
boolean
C0009488 (UMLS CUI [1,1])
C0392760 (UMLS CUI [1,2])
C0023671 (UMLS CUI [1,3])
cancer
Item
previous history of malignant disease does not preclude entry if the expectation of relapse-free survival at 10 years is 90% or greater.
boolean
C0006826 (UMLS CUI [1])
additional criteria
Item
any factor included as exclusion criterion in the local centre's treatment policy. this is particularly relevant to patients entered into the post pathology stratum.
boolean
C0680251 (UMLS CUI [1])
time
Item
no more than 30 days can have elapsed between last breast cancer surgery (not axillary) and entry into the trial for patients in the post-pathology stratification.
boolean
C0040223 (UMLS CUI [1])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial